Fulgent Genetics FLGT
NASDAQ FLGT
$21.69 -0.16 (-0.73%)
At close: Sep 18, 2026 · 4:00 PM EDT

Fulgent Genetics (FLGT) EBIT Margin Growth (3y) (2018 - 2026)

Analysis

Fulgent Genetics (FLGT) EBIT Margin Growth (3y) (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 3,294.00
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 20.00
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 333.00
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 4,867.00
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 1,424.00
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 941.00
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 7,570.00
10 Fulgent Genetics 596.80 Mn 334.14 Mn 25.68 Mn -1,307.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,307.00
Mar 31, 2026 -1,115.00
Dec 31, 2025 -8,128.00
Sep 30, 2025 -1,859.00
Jun 30, 2025 -3,431.00
Mar 31, 2025 -9,000.00
Dec 31, 2024 -8,111.00
Sep 30, 2024 -9,370.00
Jun 30, 2024 -9,100.00
Mar 31, 2024 -10,807.00
Dec 31, 2023 -29,093.00
Sep 30, 2023 -6,220.00
Jun 30, 2023 -4,447.00
Mar 31, 2023 -1,283.00
Dec 31, 2022 -3,885.00
Sep 30, 2022 -1,425.00
Jun 30, 2022 671.00
Mar 31, 2022 9,700.00
Dec 31, 2021 7,808.00
Sep 30, 2021 8,494.00